Latest Shareholder Dilution News

Anson Resources has locked in a substantial $194 million business incentive from the Utah Inland Port Authority to support its Green River Lithium Project, underpinning the financing of its planned 10,000tpa lithium carbonate plant.

NewPeak Metals has finalised its second tranche placement, issuing over 231 million shares and raising $2.86 million before costs, including repayment of director entitlements.

Neurizon Therapeutics has completed enrolment in its pivotal HEALEY ALS Platform Trial ahead of schedule, secured critical manufacturing and funding agreements, and reduced its net loss for FY2026 while preparing for topline results in late Q2 2027.

Piche Resources completed a $2.53 million entitlement offer, raising $728,324 from shareholders, with the underwriter stepping in to cover a $1.85 million shortfall. New shares and options are set to trade from 31 August 2026.

Pacific Resources Limited (ASX: PXR) completed a strategic pivot in FY2026, acquiring the high-grade Snowstorm Gold Project in Victoria and expanding exploration in Tasmania, while maintaining its Queensland coal assets. The company reported a $769K loss on no operating revenue, supported by a $1.5 million capital raise.

Adherium has tapped its major shareholder, Trudell Medical, for a further AUD 1 million unsecured loan to bolster working capital, adding to a recent USD 1.65 million facility.

RLF AgTech is set to raise $3.9 million through a share placement and convertible notes, aiming to capitalise on recent operational restructuring and accelerate commercial execution in FY27.

PM Capital Global Opportunities Fund (ASX: PGF) is raising up to $195 million through a $175 million placement and a $20 million share purchase plan at $3.07 per share, matching its net tangible asset value and offering a fully franked 7.5 cent dividend for 2026.

Percheron Therapeutics announces Dr Michael Baker as incoming CEO, replacing Dr James Garner who steps down after three years. Baker’s appointment aligns executive incentives with shareholder value as the company prepares for a pivotal HMBD-002 clinical trial.

WAM Income Maximiser (ASX: WMX) has kicked off a $125.4 million entitlement offer priced at $1.62 per share, alongside a $47 million placement, aiming to bolster its capital base while maintaining a 7.1% fully franked dividend yield.

Anson Resources has secured a conditional US$357.7 million incentive package proposal from Utah authorities, potentially easing capital and tax burdens for its Green River Lithium Project and enhancing its financial outlook.

Mayfield Childcare has launched a $3 million entitlement offer, fully covered by major shareholder pre-commitments and partial underwriting, to bolster working capital and support its operational turnaround amid ongoing sector challenges.